Toggle light / dark theme

Customised immunotherapy for treating cancer is part of the new generation of biotech solutions to diseases.


UC San Francisco scientists have engineered human immune cells that can precisely locate diseased cells anywhere in the body and execute a wide range of customizable responses, including the delivery of drugs or other therapeutic payloads directly to tumors or other unhealthy tissues. In experiments with mice, these immune cells, called synNotch T cells, efficiently homed in on tumors and released a specialized antibody therapy, eradicating the cancer without attacking normal cells.

As reported in the Sept. 29, 2016, online edition of Cell, in addition to delivering therapeutic agents, synNotch can be programmed to kill cancer cells in a variety of other ways. But synNotch cells can also carry out instructions that suppress the immune response, offering the possibility that these cells could be used to treat autoimmune diseases such as type 1 diabetes or to locally suppress immune system rejection of transplanted organs.

“SynNotch is a universal molecular sensor that allows us to program as if they were microscopic robots,” said Wendell Lim, PhD, chair and professor of cellular and molecular pharmacology at UCSF, Howard Hughes Medical Institute investigator, and member of the UCSF Helen Diller Family Comprehensive Cancer Center. “They can be customized with different features and functions, and when they detect the appropriate signals in a diseased tissue, they can be triggered to deploy diverse therapeutic weapons.”

Read more

UK researchers from five major universities close in on a cure for HIV by reprogramming immune cells to recognize the virus and destroy it.


A British man could become the first person in the world to be cured of HIV using a new therapy designed by a team of scientists from five UK universities.

The 44-year-old is one of 50 people currently trialling a treatment which targets the disease even in its dormant state.

Scientists told The Sunday Times that presently the virus is completely undetectable in the man’s blood, although that could be a result of regular drugs. However if the dormant cells are also cleared out it could represent the first complete cure. Trial results are expected to be published in 2018.

I never get tired in circuitry thread and any new findings.


Tufts University engineers say that revolutionary health diagnostics may be hanging on a thread—one of many threads they have created that integrate nano-scale sensors, electronics and microfluidics into threads ranging from simple cotton to sophisticated synthetics. “We think thread-based devices could potentially be used as smart sutures for surgical implants, smart bandages to monitor wound healing, or integrated with textile or fabric as personalized health monitors and point-of-care diagnostics,” says Sameer Sonkusale, Ph.D., director of the interdisciplinary Nano Lab in the Department of Electrical and Computer Engineering at Tufts School of Engineering, Medford/Somerville, Mass.

Researchers dipped a variety of conductive threads in physical and chemical sensing compounds and connected them to wireless electronic circuitry. The threads, sutured into tissues of rats, collected data on tissue health (pressure, stress, strain and temperature), pH and glucose levels. The data helps determine how wounds are healing, whether infection is emerging or whether the body’s chemistry is out of balance. Thread’s natural wicking properties draw fluids to the sensing compounds. Resulting data is transmitted wirelessly to a cell phone and computer.

To date, substrates for implantable devices have been two-dimensional, expensive and difficult to process, making them suitable for flat tissue, such as skin, but not for organs. “By contrast, thread is abundant, inexpensive, thin and flexible, and can be easily manipulated into complex shapes,” says Pooria Mostafalu, Ph.D., postdoctoral research fellow with the Harvard-MIT Division of Health Sciences and Technology and former Tufts doctoral student.

More progress in repairing damage to the cornea which could have implications for aging research as well as for injury.


Media Contacts: Suzanne Day Media Relations, Mass. Eye and Ear 617−573−3897 [email protected]

New findings may pave the way for the development of pharmaceutical therapies to reverse corneal scarring

Boston, Mass. — In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells (MSCs) — which can differentiate into a variety of cells, including bone, cartilage, muscle and fat cells — are capable of returning clarity to scarred corneas; however, the mechanisms by which this happens remained a mystery — until now. In a study published online today in Stem Cell Reports, researchers from Schepens Eye Research Institute of Massachusetts Eye and Ear have identified hepatocyte growth factor (HGF), secreted by MSCs, as the key factor responsible for promoting wound healing and reducing inflammation in preclinical models of corneal injury. Their findings suggest that HGF-based treatments may be effective in restoring vision in patients with severely scarred corneas.

Nice.


Researchers have come up with a way for making functional neurons directly from human skin cells, including those taken from patients with Alzheimer’s disease. Alzheimer’s Reading Room Asa Abeliovich The new method may offer a critical short cut for generating neurons for replacement therapies of the future, according to research published in the August 5th …“Scientists Make Neurons Directly From Human Skin”

Read more

Nice POV read.


We know that emerging innovations within cutting-edge science and technology (S&T) areas carry the potential to revolutionize governmental structures, economies, and life as we know it. Yet, others have argued that such technologies could yield doomsday scenarios and that military applications of such technologies have even greater potential than nuclear weapons to radically change the balance of power. These S&T areas include robotics and autonomous unmanned system; artificial intelligence; biotechnology, including synthetic and systems biology; the cognitive neurosciences; nanotechnology, including stealth meta-materials; additive manufacturing (aka 3D printing); and the intersection of each with information and computing technologies, i.e., cyber-everything. These concepts and the underlying strategic importance were articulated at the multi-national level in NATO’s May 2010 New Strategic Concept paper: “Less predictable is the possibility that research breakthroughs will transform the technological battlefield … The most destructive periods of history tend to be those when the means of aggression have gained the upper hand in the art of waging war.”

As new and unpredicted technologies are emerging at a seemingly unprecedented pace globally, communication of those new discoveries is occurring faster than ever, meaning that the unique ownership of a new technology is no longer a sufficient position, if not impossible. They’re becoming cheaper and more readily available. In today’s world, recognition of the potential applications of a technology and a sense of purpose in exploiting it are far more important than simply having access to it.

While the suggestions like those that nanotechnology will enable a new class of weapons that will alter the geopolitical landscape remain unrealized, a number of unresolved security puzzles underlying emerging technologies have implications for international security, defense policy, deterrence, governance, and arms control regimes.